Compare Amylx Pharmaceuticals Inc (AMLX) vs Devon Energy Corp (DVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Devon Energy Corp — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Devon Energy Corp trades at $45.35 (market cap $49.94B). The key difference: Devon Energy Corp is far larger — about 18.9× Amylx Pharmaceuticals Inc's market cap, and Devon Energy Corp pays a 2.82% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | DVN | |
|---|---|---|
Market Cap | $2.64B | $49.94B |
Sector | Health | Energy |
52-Week High | $24.19 | $52.07 |
52-Week Low | $7.82 | $31.74 |
Enterprise Value | $2.39B | $60.68B |
Dividend Yield | — | 2.82% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Devon Energy Corp
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →
